China Showcase Panel: Life Science Investing in China's Golden Age
January 12, 2022 at 05:21 AM EST
It is the Golden Age for Investing in China Life Science with activity levels rising steadily for six years in a row. Greg Scott, Founder and CEO of ChinaBio®, talked with a panel of China investment fund managers about their plans for 2022. What adjustments do you make when the level of China life science activity is already high? The panel, whose comments are summarized in the article, is a featured event in the virtual China Showcase, part of Biotech Showcase™, co-sponsored by Demy Colton and EBD Group. The Showcase takes place January 10-12. Share this with colleagues: // //
